Contribution of UGT2B17 to the Pharmacokinetics of Diclofenac

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

December 18, 2025

Study Completion Date

August 18, 2026

Conditions

Interaction

Interventions

DRUG

Diclofenac

25 mg capsule

DIETARY_SUPPLEMENT

curcumin

2,000 mg tablet

Trial Locations (1)

RECRUITING

Washington State University College of Pharmacy and Pharmaceutical Sciences, Spokane

All Listed Sponsors

lead

Washington State University

OTHER